# ORPHENADRINE CITRATE
> **ANDA084779** · Abbreviated New Drug Application (Generic) · Sponsor: WATSON LABS · Approved 1982-03-15
## Drug
- **FDA Application Number:** ANDA084779
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** ORPHENADRINE CITRATE
- **Generic name:** ORPHENADRINE CITRATE
- **Active ingredients:** ORPHENADRINE CITRATE
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** WATSON LABS
- **Manufacturer:** Actavis Pharma, Inc.
- **First approval:** 1982-03-15
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=084779)
---
*MORVS · CC0 1.0*